β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation

• Published in: The European journal of neuroscience 2010-10, Vol.32 (7), p.1223-1238
• Main Authors: Cai, Yan, Xiong, Kun, Zhang, Xue-Mei, Cai, Huaibin, Luo, Xue-Gang, Feng, Jia-Chun, Clough, Richard W., Struble, Robert G., Patrylo, Peter R., Chu, Yaping, Kordower, Jeffrey H., Yan, Xiao-Xin
• Format: Article
• Language: English
• Subjects: aging; Aging - pathology; Alzheimer Disease - pathology; Amyloid beta-Peptides - metabolism; Amyloid Precursor Protein Secretases - metabolism; Animals; Aspartic Acid Endopeptidases - metabolism; Blood Vessels - metabolism; Blood Vessels - pathology; Blood Vessels - ultrastructure; Cerebral Cortex - enzymology; Cerebral Cortex - pathology; dementia; Electron Transport Complex IV; Female; Gene Expression Regulation - physiology; Humans; hypometabolism; Macaca mulatta; Male; Molecular Weight; NADPH Dehydrogenase; Nerve Tissue Proteins - metabolism; neuritic plaque; neuroplasticity; non-human primate; Plaque, Amyloid - metabolism; Plaque, Amyloid - pathology; Plaque, Amyloid - ultrastructure; Postmortem Changes; Presynaptic Terminals - metabolism; Presynaptic Terminals - pathology; Silver Staining - methods; Statistics, Nonparametric; tau Proteins - metabolism
• ISSN: 0953-816X; 1460-9568
• DOI: 10.1111/j.1460-9568.2010.07376.x

Alzheimer’s disease (AD) is the most common dementia‐causing disorder in the elderly; it may be related to multiple risk factors, and is characterized pathologically by cerebral hypometabolism, paravascular β‐amyloid peptide (Aβ) plaques, neuritic dystrophy, and intra‐neuronal aggregation of phosphorylated tau. To explore potential pathogenic links among some of these lesions, we examined β‐secretase‐1 (BACE1) alterations relative to Aβ deposition, neuritic pathology and vascular organization in aged monkey and AD human cerebral cortex. Western blot analyses detected increased levels of BACE1 protein and β‐site‐cleavage amyloid precursor protein C‐terminal fragments in plaque‐bearing human and monkey cortex relative to controls. In immunohistochemistry, locally elevated BACE1 immunoreactivity (IR) occurred in AD but not in control human cortex, with a trend for increased overall density among cases with greater plaque pathology. In double‐labeling preparations, BACE1 IR colocalized with immunolabeling for Aβ but not for phosphorylated tau. In perfusion‐fixed monkey cortex, locally increased BACE1 IR co‐existed with intra‐axonal and extracellular Aβ IR among virtually all neuritic plaques, ranging from primitive to typical cored forms. This BACE1 labeling localized to swollen/sprouting axon terminals that might co‐express one or another neuronal phenotype markers (GABAergic, glutamatergic, cholinergic, or catecholaminergic). Importantly, these BACE1‐labeled dystrophic axons resided near to or in direct contact with blood vessels. These findings suggest that plaque formation in AD or normal aged primates relates to a multisystem axonal pathogenesis that occurs in partnership with a potential vascular or metabolic deficit. The data provide a mechanistic explanation for why senile plaques are present preferentially near the cerebral vasculature.